Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Nirav N. Shah, Michael Wang, Lindsey E. Roeker, Krish Patel, Jennifer A. Woyach, William G. Wierda, Chaitra S. Ujjani, Toby A. Eyre, Pier Luigi Zinzani, Alvaro J. Alencar, Paolo Ghia, Nicole Lamanna, Marc S. Hoffmann, Manish R. Patel, Ian Flinn, James N. Gerson, Shuo Ma, Catherine C. Coombs, Chan Y. Cheah, Ewa Lech-Maranda, Bita Fakhri, Won Seog Kim, Minal A. Barve, Jonathon B. Cohen, Wojciech Jurczak, Talha Munir, Meghan C. Thompson, Donald E. Tsai, Katherine Bao, Nicholas A. Cangemi, Jennifer F. Kherani, Richard A. Walgren, Hongmei Han, Amy S. Ruppert, Jennifer R. Brown

Open source

DOI: 10.3324/haematol.2024.285754
Published: 2024-10-03
Container: Haematologica
Publisher: Ferrata Storti Foundation (Haematologica)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2024.285754,
  title = {Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial},
  author = {Nirav N. Shah and Michael Wang and Lindsey E. Roeker and Krish Patel and Jennifer A. Woyach and William G. Wierda and Chaitra S. Ujjani and Toby A. Eyre and Pier Luigi Zinzani and Alvaro J. Alencar and Paolo Ghia and Nicole Lamanna and Marc S. Hoffmann and Manish R. Patel and Ian Flinn and James N. Gerson and Shuo Ma and Catherine C. Coombs and Chan Y. Cheah and Ewa Lech-Maranda and Bita Fakhri and Won Seog Kim and Minal A. Barve and Jonathon B. Cohen and Wojciech Jurczak and Talha Munir and Meghan C. Thompson and Donald E. Tsai and Katherine Bao and Nicholas A. Cangemi and Jennifer F. Kherani and Richard A. Walgren and Hongmei Han and Amy S. Ruppert and Jennifer R. Brown},
  year = {2024},
  journal = {Haematologica},
  doi = {10.3324/haematol.2024.285754},
  url = {https://doi.org/10.3324/haematol.2024.285754}
}

RIS

TY  - JOUR
TI  - Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial
AU  - Nirav N. Shah
AU  - Michael Wang
AU  - Lindsey E. Roeker
AU  - Krish Patel
AU  - Jennifer A. Woyach
AU  - William G. Wierda
AU  - Chaitra S. Ujjani
AU  - Toby A. Eyre
AU  - Pier Luigi Zinzani
AU  - Alvaro J. Alencar
AU  - Paolo Ghia
AU  - Nicole Lamanna
AU  - Marc S. Hoffmann
AU  - Manish R. Patel
AU  - Ian Flinn
AU  - James N. Gerson
AU  - Shuo Ma
AU  - Catherine C. Coombs
AU  - Chan Y. Cheah
AU  - Ewa Lech-Maranda
AU  - Bita Fakhri
AU  - Won Seog Kim
AU  - Minal A. Barve
AU  - Jonathon B. Cohen
AU  - Wojciech Jurczak
AU  - Talha Munir
AU  - Meghan C. Thompson
AU  - Donald E. Tsai
AU  - Katherine Bao
AU  - Nicholas A. Cangemi
AU  - Jennifer F. Kherani
AU  - Richard A. Walgren
AU  - Hongmei Han
AU  - Amy S. Ruppert
AU  - Jennifer R. Brown
PY  - 2024
JO  - Haematologica
DO  - 10.3324/haematol.2024.285754
UR  - https://doi.org/10.3324/haematol.2024.285754
ER  -

APA

Shah, N. N., Wang, M., Roeker, L. E., Patel, K., Woyach, J. A., Wierda, W. G., Ujjani, C. S., Eyre, T. A., Zinzani, P. L., Alencar, A. J., Ghia, P., Lamanna, N., Hoffmann, M. S., Patel, M. R., Flinn, I., Gerson, J. N., Ma, S., Coombs, C. C., Cheah, C. Y., Lech-Maranda, E., Fakhri, B., Kim, W. S., Barve, M. A., Cohen, J. B., Jurczak, W., Munir, T., Thompson, M. C., Tsai, D. E., Bao, K., Cangemi, N. A., Kherani, J. F., Walgren, R. A., Han, H., Ruppert, A. S., & Brown, J. R. (2024). Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial. Haematologica. https://doi.org/10.3324/haematol.2024.285754

Source records

crossref · retrieved 2026-09-26T03:30:25.328Z